Instem plc Issue of Equity, TVRs & PDMR Dealing (2507L)
17 July 2017 - 8:27PM
UK Regulatory
TIDMINS
RNS Number : 2507L
Instem plc
17 July 2017
Instem plc
("Instem" or the "Company")
Issue of Equity, Total Voting Rights and PDMR Dealing
Instem plc (AIM: INS), a leading provider of IT solutions to the
global early development healthcare market, announces that,
following the exercise of vested EMI share options by an employee,
1,500 ordinary shares of 10p each in the Company ("Ordinary
Shares") have been issued.
Application will be made to the London Stock Exchange for the
admission of the 1,500 new Ordinary Shares to trading on AIM.
Admission is expected to take place at 8.00am on 19 July 2017.
Total Voting Rights
Following the issue and allotment of the above New Ordinary
Shares, the Company's issued share capital comprises 15,866,660
Ordinary Shares. The Company does not hold any Ordinary Shares in
treasury. Therefore the total number of voting rights in the
Company is 15,866,660.
The figure of 15,866,660 may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change of their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
PDMR Dealing
The Company was notified on 13 July that on 12 July 2017, the DG
2008 Discretionary Settlement (of which David Gare (the Company
chairman) and his wife are the trustees) transferred 10,000
Ordinary Shares to David's son Adrian Gare and a further 10,000 to
his daughter, Debbie Walker, for nil consideration. Following the
transaction, the DG 2008 Discretionary Settlement now has a total
interest in 1,398,427 Ordinary Shares, representing approximately
8.81% of the Company's issued share capital.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging
managerial responsibilities / person
closely associated
---- ----------------------------------------------------------------
a) Name David Gare (via the DG
2008 Discretionary Settlement)
---- ------------------------- -------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------
a) Position/status Chairman of the Company
---- ------------------------- -------------------------------------
b) Initial notification Initial
/Amendment
---- ------------------------- -------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
---- ----------------------------------------------------------------
a) Name Instem plc
---- ------------------------- -------------------------------------
b) LEI 213800PILYUFNNROQX68
---- ------------------------- -------------------------------------
4 Details of the transaction(s): section
to be repeated for (i) each type of
instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place
where transactions have been conducted
---- ----------------------------------------------------------------
a) Description Ordinary shares of 10p
of the financial each
instrument,
type of instrument
----
Identification GB00B3TQCK30
code
b) Nature of the Transfer of ordinary
transaction shares
---- ------------------------- -------------------------------------
c) Price(s) and
volume(s)
---- --------------- -----------------
Price(s) Volume(s)
---- --------------- -----------------
0p 10,000
--------------- -----------------
d) Aggregated
information
----
- Aggregated N/A
volume
- Price
e) Date of the 12 July 2017
transaction
---- ------------------------- -------------------------------------
f) Place of the London Stock Exchange
transaction (XLON)
---- ------------------------- -------------------------------------
4 Details of the transaction(s): section
to be repeated for (i) each type of
instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place
where transactions have been conducted
---- ----------------------------------------------------------------
a) Description Ordinary shares of 10p
of the financial each
instrument,
type of instrument
----
Identification GB00B3TQCK30
code
b) Nature of the Transfer of ordinary
transaction shares
---- ------------------------- -------------------------------------
c) Price(s) and
volume(s)
---- --------------- -----------------
Price(s) Volume(s)
---- --------------- -----------------
0p 10,000
--------------- -----------------
d) Aggregated
information
----
- Aggregated N/A
volume
- Price
e) Date of the 12 July 2017
transaction
---- ------------------------- -------------------------------------
f) Place of the London Stock Exchange
transaction (XLON)
---- ------------------------- -------------------------------------
For further information, please contact:
Instem plc +44 (0) 1785 825 600
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated
Adviser & Broker) +44 (0) 20 7496 3000
Richard Lindley
James White
Walbrook Financial PR +44 (0) 20 7933 8780
Paul Cornelius instem@walbrookpr.com
Helen Cresswell
Sam Allen
Paul Whittington
About Instem
Instem is a leading supplier of IT applications and services to
the early development healthcare market delivering compelling
solutions for data collection, analysis and regulatory submissions
management. Instem solutions are in use by customers worldwide,
meeting the rapidly expanding needs of life science and healthcare
organisations for data-driven decision making leading to safer,
more effective products.
Instem's portfolio of software solutions increases client
productivity by automating study-related processes while offering
the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United
States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please
visit www.instem.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEBGGDRLDBBGRR
(END) Dow Jones Newswires
July 17, 2017 06:27 ET (10:27 GMT)
Instem (LSE:INS)
Historical Stock Chart
From Apr 2024 to May 2024
Instem (LSE:INS)
Historical Stock Chart
From May 2023 to May 2024